Last Updated: July 12, 2024
clinicaltrialsandresearch.vic.gov.au has 4 NS records, 2 A records, 0 AAAA records, 2 MX records, and 1 TXT records. Name servers for clinicaltrialsandresearch.vic.gov.au are ns-439.awsdns-54.com, ns-1324.awsdns-37.org, ns-1916.awsdns-47.co.uk, ns-706.awsdns-24.net. A records for clinicaltrialsandresearch.vic.gov.au are 45.60.78.66, 45.60.81.66. MX records that process @clinicaltrialsandresearch.vic.gov.au email are mxb-001fc401.gslb.pphosted.com, mxa-001fc401.gslb.pphosted.com. We have observed clinicaltrialsandresearch.vic.gov.au to have 2 subdomains. A subdomain count of 2 is considered a small digital footprint. Technology that may be in use at clinicaltrialsandresearch.vic.gov.au includes globalsign.
Search DigitalStakeout ASI to find another asset.
45.60.78.66
45.60.81.66
No DNS AAAA records
mxb-001fc401.gslb.pphosted.com
mxa-001fc401.gslb.pphosted.com
ns-439.awsdns-54.com
ns-1324.awsdns-37.org
ns-1916.awsdns-47.co.uk
ns-706.awsdns-24.net
clinicaltrialsandresearch.vic.gov.au. 300 IN TXT "globalsign-domain-verification=81c1474ea27406129b61281b4798e64b"
clinicaltrialsandresearch.vic.gov.au has 2 subdomains in our inventory.
openresty
United States
{"data":{"cert_index":876643060,"cert_link":"https:\/\/ct.googleapis.com\/logs\/eu1\/xenon2024\/ct\/v1\/get-entries?start=876643060&end=876643060","leaf_cert":{"all_domains":["clinicaltrialsandresearch.vic.gov.au","imperva.com"],"extensions":{"authorityInfoAccess":"CA Issuers - URI:http:\/\/secure.globalsign.com\/cacert\/gsatlasr3dvtlsca2024q1.crt\nOCSP - URI:http:\/\/ocsp.globalsign.com\/ca\/gsatlasr3dvtlsca2024q1\n","authorityKeyIdentifier":"keyid:66:C0:C7:A3:9A:CD:FE:F3:EA:CE:4B:53:0B:61:5E:AF:33:05:B3:E1\n","basicConstraints":"CA:FALSE","certificatePolicies":"Policy: 1.3.6.1.4.1.4146.10.1.3\n CPS: https:\/\/www.globalsign.com\/repository\/","crlDistributionPoints":"Full Name:\n URI:http:\/\/crl.globalsign.com\/ca\/gsatlasr3dvtlsca2024q1.crl","ctlPoisonByte":true,"extendedKeyUsage":"TLS Web server authentication, TLS Web client authentication","keyUsage":"Digital Signature, Key Encipherment","subjectAltName":"DNS:imperva.com, DNS:clinicaltrialsandresearch.vic.gov.au","subjectKeyIdentifier":"B2:F9:EA:64:ED:3C:02:7F:5B:DD:91:0A:A1:09:4A:9B:BB:FD:9B:42"},"fingerprint":"49:A1:86:94:DA:2F:0B:7C:6D:BA:D7:87:69:54:4E:FA:5C:F0:B1:7C","issuer":{"C":"BE","CN":"GlobalSign Atlas R3 DV TLS CA 2024 Q1","L":null,"O":"GlobalSign nv-sa","OU":null,"ST":null,"aggregated":"\/C=BE\/CN=GlobalSign Atlas R3 DV TLS CA 2024 Q1\/O=GlobalSign nv-sa","emailAddress":null},"not_after":1704962166,"not_before":1704875766,"serial_number":"177D15CC1D0E52A43F499665348F435","signature_algorithm":"sha256, rsa","subject":{"C":null,"CN":"imperva.com","L":null,"O":null,"OU":null,"ST":null,"aggregated":"\/CN=imperva.com","emailAddress":null}},"seen":1704875939.757995,"source":{"name":"Google 'Xenon2024' log","url":"https:\/\/ct.googleapis.com\/logs\/eu1\/xenon2024\/"},"update_type":"PrecertLogEntry"},"message_type":"certificate_update"}